Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE: 000623)

Jilin Aodong Pharmaceutical Group Revenue

Jilin Aodong Pharmaceutical Group had revenue of 497.77M CNY in the quarter ending September 30, 2024, a decrease of -35.42%. This brings the company's revenue in the last twelve months to 3.00B, down -9.20% year-over-year. In the year 2023, Jilin Aodong Pharmaceutical Group had annual revenue of 3.45B with 20.25% growth.

• Revenue (ttm): 3.00B
• Revenue Growth: -9.20%
• P/S Ratio: 7.06
• Revenue / Employee: 532.20K
• Employees: 5,646
• Market Cap: 21.90B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	3.45B	580.91M	20.25%
Jan 1, 2023	2.87B	564.45M	24.50%
Jan 1, 2022	2.30B	52.11M	2.31%
Dec 31, 2020	2.25B	-836.73M	-27.09%
Dec 31, 2019	3.09B	-235.70M	-7.09%